- Patent Title: Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof
-
Application No.: US17203291Application Date: 2021-03-16
-
Publication No.: US11746155B2Publication Date: 2023-09-05
- Inventor: Antara Banerjee , Andrea Fanjul , Robert J. Hoey , Kacey Sachen , Nikolai Suslov
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present disclosure provides isolated, engineered, non-naturally occurring CB1 binding proteins, including anti-CB1 antibodies or antigen-binding fragment thereof. The CB1 binding proteins find utility in the treatment and diagnosis of CB1 mediated conditions, diseases and disorders.
Public/Granted literature
- US20210198358A1 CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF Public/Granted day:2021-07-01
Information query
